Related Experiment Video
Updated: Jan 3, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
The Future of Biomarkers
Jean-Louis Vincent1, Elisa Bogossian1, Marco Menozzi1
1Department of Intensive Care, Erasme Hospital, Université libre de Bruxelles, Route de Lennik 808, Brussels 1070, Belgium.
Single biomarkers are insufficient for critical illness. Future intensive care medicine will rely on combinations of multiple biomarkers for accurate diagnosis and personalized treatment, improving patient outcomes.
Area of Science:
- Critical care medicine
- Biomarker discovery
- Translational research
Background:
- Single biomarkers lack specificity and sensitivity for complex critical illnesses.
- Past research focused on individual markers, yielding limited success.
- Intensive care medicine requires improved diagnostic and prognostic tools.
Purpose of the Study:
- To highlight the limitations of single biomarkers in critical care.
- To emphasize the emerging trend towards multi-biomarker strategies.
- To discuss the future role of biomarkers in clinical practice.
Main Methods:
- Review of current literature on biomarker research in intensive care.
- Analysis of technological advancements in biomarker detection.
- Examination of large-scale patient databases for biomarker identification.
Main Results:
- No single biomarker is adequate for diagnosing heterogeneous critical illnesses.
- Combinations of multiple biomarkers offer greater potential for specificity and sensitivity.
- New technologies and big data are enabling novel biomarker discovery.
Conclusions:
- The future of critical care diagnostics lies in multi-biomarker panels.
- Biomarkers will become integral to routine clinical practice.
- Integrated biomarker approaches will enhance disease diagnosis, complication prediction, personalized treatment, and prognosis.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Microorganisms in Medicine and Therapeutics
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

